Lyme Disease Diagnostics Devices Market: By Product Type (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic Acid Test), By Sample (Blood, Cerebrospinal Fluid [CSF], Joint Fluid, Urine), By End User

Lyme Disease Diagnostics Devices Market: By Product Type (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic Acid Test), By Sample (Blood, Cerebrospinal Fluid [CSF], Joint Fluid, Urine), By End User (Hospitals, Public/Private Laboratories, Physician’s Office), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032

Market Overview

The report, Lyme Disease Diagnostics Devices Market- Analysis of Market Size, Share & Trends for 2014 - 2022 and Forecasts to 2032, was published by Fatpos Global and is expected to reach Market Value. Fatpos Global conducted a study. The report, in order to provide a thorough understanding of the global market, emphasises the detailed understanding of some key factors, such as size, share, sales, forecast trends, supply, production, demands, industry, and CAGR.

The Lyme Disease Diagnostics Devices Market grew from USD 1.83 billion in 2022 to USD 3.8 billion by 3032, exhibiting a CAGR of 6.9% during the forecast period.

Key Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Abbott
  • Quest Diagnostics
  • PerkinElmer Inc.
  • Bio-Rad Laboratories
  • DiaSorin S.p.A
  • Quidel Corporation
  • Meridian Bioscience Inc
  • Graphene Frontiers
  • T2 Biosystems Inc.
  • IGeneX Inc.
  • Cenogenics Corporation
  • Ceres Nanosciences Inc.
  • Trinity Biotech plc
  • Lyme Diagnostics Ltd.
  • Other Prominent Players
Lyme Disease Diagnostics Devices Market: Segmentation
  • By Product Type
  • Serological Test
  • Urine Antigen Tests
  • Lymphocytic Transformation Test
  • Immunofluorescent Staining
  • Nucleic Acid Test
  • By Sample
  • Blood
  • Cerebrospinal Fluid (CSF)
  • Joint Fluid
  • Urine
  • By End User
  • Hospitals
  • Public/Private Laboratories
  • Physician’s Office
  • Lyme Disease Diagnostics Devices Market Dynamics
  • Size Supply and Demand Lyme Disease Diagnostics Devices Market
  • Current Issues/Trends/Challenges
  • Companies and Competition Market Drivers and Restraints Involved in the Market Value Chain
  • The report sheds light on various aspects and provides answers to pertinent market questions. Among the most important are:
  • Pre- and post-business impact analysis of COVID-19
  • A thorough examination of the parent market
  • Market dynamics in the industry are changing.
  • Market segmentation in depth
  • What is the Lyme Disease Diagnostics Devices Market expansion?
  • Which segment had the highest Lyme Disease Diagnostics Devices Market share?
  • Who are the main characters in Lyme Disease Diagnostics Devices Market?
  • Historical, current, and projected market volumes and values
  • Trends and developments in the industry recently
  • The competitive environment
  • Key players' strategies and products on offer
  • Potential and niche segments, as well as geographical regions with promising growth prospects
  • A balanced assessment of market performance
  • Information that markets participants must have in order to maintain and expand their market footprint.
Note: Although Fatpos Global has taken great care to ensure the highest levels of accuracy in its studies, it might take some time for significant changes to the market or a particular vendor to be reflected in the research.

*Please Note: The report will be delivered in 4-5 business days upon order confirmation*


1 Executive Summary
2 Global Lyme Disease Diagnostics Devices Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 Average Pricing Analysis
5 Macro-Economic Indicators
6 Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8 Recent Development, Policies & Regulatory Landscape
9 Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 Global Lyme Disease Diagnostics Devices Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 Global Lyme Disease Diagnostics Devices Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12 Global Oncology Pharmaceuticals Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
12.2.1. Chemotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Targeted Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Immunotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Hormonal Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Indication: Market Share (2020-2030F)
12.3.1. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Stomach Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Breast Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Prostate Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By End user: Market Share (2020-2030F)
12.4.1. Specialized cancer treatment centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Hospitals Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13 Company Profile
Thermo Fisher Scientific Inc.
Abbott
Quest Diagnostics
PerkinElmer Inc.
Bio-Rad Laboratories
DiaSorin S.p.A
Quidel Corporation
Meridian Bioscience Inc
Graphene Frontiers
T2 Biosystems Inc.
IGeneX Inc.
Cenogenics Corporation
Ceres Nanosciences Inc.
Trinity Biotech plc
Lyme Diagnostics Ltd.
Other Prominent Players
14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings